UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 10-Q

 

 

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended OctoberJanuary 31, 20092010

or

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period fromto                

Commission file number 0-5286

 

 

KEWAUNEE SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware 38-0715562

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

2700 West Front Street

Statesville, North Carolina

 28677-2927
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (704) 873-7202

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes x    No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive DatesData File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this Chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes ¨    No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ¨ Accelerated filer ¨ 

Non-accelerated filer ¨

(Do not check if a smaller

reporting company)

 Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act).    Yes ¨    No x

As of December 7, 2009,March 2, 2010, the registrant had outstanding 2,569,3102,572,743 shares of Common Stock.

 

 

 


KEWAUNEE SCIENTIFIC CORPORATION

INDEX TO FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED OCTOBERJANUARY 31, 20092010

 

     Page Number
PART I. FINANCIAL INFORMATION  1
Item 1. 

Financial Statements

  1
 

Consolidated Statements of Operations – Three and SixNine months ended OctoberJanuary 31, 20092010 and 20082009

  1
 

Consolidated Balance Sheets October– January 31, 20092010 and April 30, 2009

  2
 

Consolidated Statements of Cash Flows – SixNine months ended OctoberJanuary 31, 20092010 and 20082009

  3
 

Notes to Consolidated Financial Statements

  4
Item 2. 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  6
 

Review by Independent Registered Public Accounting Firm

  89
 

Report of Independent Registered Public Accounting Firm

  910
Item 3. 

Quantitative and Qualitative Disclosures About Market Risk

  1011
Item 4. 

Controls and Procedures

  1011

PART II. OTHER INFORMATION

  11
Item 4.

Submission of Matters to a Vote of Security Holders

11
Item 6. 

Exhibits

  1112

SIGNATURE

  1213

 

i


Part 1. Financial Information

 

Item 1.Financial Statements

Kewaunee Scientific Corporation

Consolidated Statements of Operations

(Unaudited)

(in thousands, except per share data)

 

  Three months ended
October 31
 Six months ended
October 31
   Three months ended
January 31
 Nine months ended
January 31
 
  2009 2008 2009 2008   2010 2009 2010 2009 

Net Sales

  $27,088   $27,732   $53,337   $53,127  

Net sales

  $21,814   $26,023   $75,151   $79,150  

Costs of products sold

   20,878    21,713    41,363    41,757     17,129    21,089    58,492    62,846  
                          

Gross profit

   6,210    6,019    11,974    11,370     4,685    4,934    16,659    16,304  

Operating expenses

   3,976    3,858    7,942    7,444     3,663    3,440    11,605    10,884  
                          

Operating earnings

   2,234    2,161    4,032    3,926     1,022    1,494    5,054    5,420  

Other expense

   —      (1  —      (39

Other income (expense)

   —      3    —      (36

Interest expense

   (39  (93  (80  (182   (35  (49  (115  (231
                          

Earnings before income taxes

   2,195    2,067    3,952    3,705     987    1,448    4,939    5,153  

Income tax expense

   751    566    1,340    1,107     333    488    1,673    1,595  
                          

Net earnings

   1,444    1,501    2,612    2,598     654    960    3,266    3,558  

Less: net earnings attributable to the noncontrolling interest

   92    37    189    153     33    78    222    231  
                          

Net earnings attributable to Kewaunee Scientific Corporation

  $1,352   $1,464   $2,423   $2,445    $621   $882   $3,044   $3,327  
                          

Net earnings per share attributable to Kewaunee Scientific Corporation stockholders

          

Basic

  $0.53   $0.57   $0.95   $0.96    $0.24   $0.35   $1.19   $1.30  

Diluted

  $0.53   $0.57   $0.95   $0.95    $0.24   $0.35   $1.18   $1.30  

Weighted average number of common shares outstanding (in thousands)

          

Basic

   2,560    2,555    2,558    2,553     2,569    2,556    2,562    2,554  

Diluted

   2,571    2,562    2,564    2,566     2,581    2,556    2,570    2,563  

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Balance Sheets

(in thousands)

 

  October 31,
2009
 April 30,
2009
   January 31,
2010
 April 30,
2009
 
  (Unaudited)     (Unaudited)   

Assets

      

Current assets:

      

Cash and cash equivalents

  $2,596   $3,559    $1,937   $3,559  

Restricted cash

   461    456     506    456  

Receivables, less allowance

   26,660    24,526     23,007    24,526  

Inventories

   8,117    7,839     7,924    7,839  

Deferred income taxes

   311    309     330    309  

Prepaid expenses and other current assets

   1,389    856     1,255    856  
              

Total current assets

   39,534    37,545     34,959    37,545  

Property, plant and equipment, at cost

   40,952    39,298     41,738    39,298  

Accumulated depreciation

   (28,560  (27,929   (29,129  (27,929
              

Net property, plant and equipment

   12,392    11,369     12,609    11,369  

Deferred income taxes

   339    351     351    351  

Other

   3,759    3,264     3,684    3,264  
              

Total other assets

   4,098    3,615     4,035    3,615  
              

Total Assets

  $56,024   $52,529    $51,603   $52,529  
              

Liabilities and Stockholders’ Equity

      

Current liabilities:

      

Short-term borrowings

  $5,370   $5,720    $2,909   $5,720  

Current obligations under capital leases

   100    220     96    220  

Accounts payable

   7,410    8,812     6,082    8,812  

Employee compensation and amounts withheld

   1,476    1,709     1,521    1,709  

Deferred revenue

   1,327    1,298     708    1,298  

Other accrued expenses

   2,971    904     2,316    904  
              

Total current liabilities

   18,654    18,663     13,632    18,663  

Obligations under capital leases

   177    201     139    201  

Accrued employee benefit plan costs

   6,371    5,406     6,533    5,406  
              

Total Liabilities

   25,202    24,270     20,304    24,270  

Equity:

      

Common Stock

   6,550    6,550     6,550    6,550  

Additional paid-in-capital

   711    614     765    614  

Retained earnings

   27,764    25,802     28,127    25,802  

Accumulated other comprehensive loss

   (5,308  (5,521   (5,298  (5,521

Common stock in treasury, at cost

   (471  (492   (470  (492
              

Total Kewaunee Scientific Corporation stockholders’ equity

   29,246    26,953     29,674    26,953  

Noncontrolling interest

   1,576    1,306     1,625    1,306  
              

Total Equity

   30,822    28,259     31,299    28,259  
              

Total Liabilities and Equity

  $56,024   $52,529  

Total Liabilities and Stockholders’ Equity

  $51,603   $52,529  
              

See accompanying notes to consolidated financial statements.

Kewaunee Scientific Corporation

Consolidated Statements of Cash Flows

(Unaudited)

(in thousands)

 

  Six months ended
October 31
   Nine months ended
January 31
 
  2009 2008   2010 2009 

Cash flows from operating activities:

      

Net earnings

  $2,423   $2,445    $3,044   $3,327  

Adjustments to reconcile net earnings to net cash used in operating activities:

   

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:

   

Depreciation

   1,255    1,135     1,840    1,687  

Bad debt provision

   71    116     107    164  

Provision for deferred income tax expense

   10    (2   (21  (10

Decrease in prepaid income taxes

   9    812    9    812  

Increase in receivables

   (2,205  (5,537

(Increase) decrease in inventories

   (278  118  

Decrease (increase) in receivables

   1,412    (4,800

Increase in inventories

   (85  (694

Increase in prepaid pension cost

   —      (148   —      (222

Increase in accounts payable and other accrued expenses

   432    698  

Increase in deferred revenue

   29    707  

(Decrease) increase in accounts payable and other accrued expenses

   (1,506  265  

(Decrease) increase in deferred revenue

   (590  364  

Other, net

   327    (847   817    (553
              

Net cash provided by (used in) operating activities

   2,073    (503

Net cash provided by operating activities

   5,027    340  

Cash flows from investing activities:

      

Capital expenditures

   (2,278  (679   (3,080  (1,156

Increase (decrease) in restricted cash

   (5  72  

(Increase) decrease in restricted cash

   (50  82  
              

Net cash used in investing activities

   (2,283  (607   (3,130  (1,074

Cash flows from financing activities:

      

(Decrease) increase in short-term borrowings

   (2,811  1,264  

Payments on capital leases

   (186  (280

Dividends paid

   (461  (408   (719  (613

Decrease (increase) in short-term borrowings

   (350  415  

Payments on capital leases

   (144  (192

Dividends paid to minority interest in subsidiaries

   —      (498

Purchase of treasury stock

   (114  (198   (245  (198

Proceeds from exercise of stock options (including tax benefit)

   135    276     267    298  
              

Net cash used in financing activities

   (934  (107   (3,694  (27

Effect of exchange rate changes on cash

   181    (285   175    (332
              

Decrease in cash and cash equivalents

   (963  (1,502   (1,622  (1,093

Cash and cash equivalents, beginning of period

   3,559    3,784     3,559    3,784  
              

Cash and cash equivalents, end of period

  $2,596   $2,282    $1,937   $2,691  
              

See accompanying notes to consolidated financial statements

Kewaunee Scientific Corporation

Notes to Consolidated Financial Statements

(unaudited)

A.Financial Information

The unaudited interim consolidated financial statements of Kewaunee Scientific Corporation (the “Company” or “Kewaunee”) have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although the Company believes that the disclosures are adequate to make the information presented not misleading.

These interim consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s 2009 Annual Report to Stockholders. The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year.

The preparation of the consolidated financial statements requires management to make certain estimates and assumptions that affect reported amounts and disclosures. Actual results could differ from those estimates. In preparing these interim consolidated financial statements, we have reviewed and considered for disclosure all significant events occurring through December 11, 2009,March 12, 2010, the date of financial statement issuance.

B.Inventories

Inventories consisted of the following (in thousands):

 

  October 31, 2009  April 30, 2009  January 31, 2010  April 30, 2009

Finished products

  $1,772  $1,756  $1,871  $1,756

Work in process

   1,534   1,461   1,521   1,461

Raw materials

   4,811   4,622   4,532   4,622
            
  $8,117  $7,839  $7,924  $7,839
            

For interim reporting, LIFO inventories are computed based on year-to-date quantities and interim changes in price levels. Changes in quantities and price levels are reflected in the interim consolidated financial statements in the period in which they occur.

C.Comprehensive Income

A reconciliation of net earnings and total comprehensive income for the three and sixnine months ended OctoberJanuary 31, 20092010 and 20082009 is as follows (in thousands):

 

  Three months ended
October 31, 2009
  Three months ended
October 31, 2008
   Three months ended
January 31, 2010
 Three months ended
January 31, 2009
 

Net earnings

  $1,352  $1,464    $621   $882  

Change in cumulative foreign currency translation adjustments

   109   (588   39    82  

Change in fair value of cash flow hedge, net of tax

   (29  —    
              

Total comprehensive income

  $1,461  $876    $631   $964  
              
  Six months ended
October 31, 2009
  Six months ended
October 31, 2008
   Nine months ended
January 31, 2010
 Nine months ended
January 31, 2009
 

Net earnings

  $2,423  $2,445    $3,044   $3,327  

Change in cumulative foreign currency translation adjustments

   213   (724   252    (642

Change in fair value of cash flow hedge, net of tax

   (29  —    
              

Total comprehensive income

  $2,636  $1,721    $3,267   $2,685  
              

Assets and liabilities for the Company’s foreign subsidiaries are translated at exchange rates prevailing on the balance sheet date. Revenues and expenses are translated at weighted average exchange rates prevailing during the period and any resulting translation adjustments are reported separately in stockholders’ equity.

D.Segment Information

The following table provides financial information by business segments for the three and sixnine months ended OctoberJanuary 31, 20092010 and 20082009 (in thousands):

 

  Domestic
Operations
  International
Operations
  Corporate Total  Domestic
Operations
  International
Operations
  Corporate Total

Three months ended October 31, 2009

       

Three months ended January 31, 2010

       

Revenues from external customers

  $24,713  $2,375  $—     $27,088  $19,081  $2,733  $—     $21,814

Intersegment revenues

   271   310   (581  —     477   23   (500  —  

Operating earnings (loss) before income taxes

   2,900   206   (911  2,195   1,538   127   (678  987

Three months ended October 31, 2008

       

Three months ended January 31, 2009

       

Revenues from external customers

  $23,785  $3,947  $—     $27,732  $22,498  $3,525   —     $26,023

Intersegment revenues

   851   21   (872  —     347   234   (581  —  

Operating earnings (loss) before incomes taxes

   2,693   309   (935  2,067

Six months ended October 31, 2009

       

Operating earnings (loss) before income taxes

   1,769   302   (623  1,448

Nine months ended January 31, 2010

       

Revenues from external customers

  $48,071  $5,266  $—     $53,337  $67,152  $7,999  $—     $75,151

Intersegment revenues

   691   417   (1,108  —     1,169   441   (1,610  —  

Operating earnings (loss) before incomes taxes

   5,445   509   (2,002  3,952

Six months ended October 31, 2008

       

Operating earnings (loss) before income taxes

   6,984   636   (2,681  4,939

Nine months ended January 31, 2009

       

Revenues from external customers

  $44,798  $8,329  $—     $53,127  $67,296  $11,854  $—     $79,150

Intersegment revenues

   1,637   25   (1,662  —     1,984   259   (2,243  —  

Operating earnings (loss) before incomes taxes

   4,732   723   (1,750  3,705

Operating earnings (loss) before income taxes

   6,501   1,025   (2,373  5,153

E.Defined Pension Plans

The Company has non-contributory defined benefit pension plans covering substantially all salaried and hourly employees. These plans were amended as of April 30, 2005, no further benefits have been, or will be, earned under the plans, subsequent to the amendment date, and no additional participants will be added to the plans. No contributions were paid to the plans during the sixnine months ended OctoberJanuary 31, 2009,2010, and the Company does not expect any contributions to be paid to the plans during the remainder of the current fiscal year.

Pension expense (income) consisted of the following (in thousands):

 

  Three months ended
October 31, 2009
 Three months ended
October 31, 2008
   Three months ended
January 31, 2010
 Three months ended
January 31, 2009
 

Service cost

  $-0-   $-0-  

Interest cost

   245    220  

Service Cost

  $-0-   $-0-  

Interest Cost

   238    224  

Expected return on plan assets

   (234  (339   (235  (338

Recognition of net loss

   187    31     174    40  
              

Net periodic pension expense (income)

  $198   $(88  $177   $(74
              
  Six months ended
October 31, 2009
 Six months ended
October 31, 2008
   Nine months ended
January 31, 2010
 Nine months ended
January 31, 2009
 

Service cost

  $-0-   $-0-  

Interest cost

   475    448  

Service Cost

  $-0-   $-0-  

Interest Cost

   713    672  

Expected return on plan assets

   (469  (676   (704  (1,014

Recognition of net loss

   347    80     521    120  
              

Net periodic pension expense (income)

  $353   $(148  $530   $(222
              

F.Credit Arrangement

In July 2009, the Company amended its unsecured revolving credit facility to extend the facility’s expiration date to July 31, 2012, and modify the variable rate component of the interest calculation. Monthly interest payments under the facility, as amended, are payable calculated at the 30-day LIBOR Market Interest Rate plus a variable rate ranging from 1.575% to 2.175%.

G.Derivative Instruments and Hedging Activities

Cash Flow Hedges – Interest Rate Swap Agreement

In July 2009, the Company entered into an interest rate SWAP agreement whereby the interest rate payable by the Company on $2 million of outstanding advances under the revolving credit facility willwas effectively convertconverted to a fixed interest rate of 3.9% for the period beginning August 3, 2009, and ending August 1, 2012.

The Company entered into this interest rate swap to mitigate future interest rate risk associated with advances under the credit facility.

The Company does not use derivatives for trading or speculative purposes. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company did not record any hedge ineffectiveness in earnings during the three months or nine months ended January 31, 2010 and 2009. Amounts reported in accumulated other comprehensive loss related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s revolving credit facility.

The change in fair value of cash flow hedge, net of tax for the three and nine months ended January 31, 2010 was $29,000. The change in fair value was recorded in the Company’s consolidated balance sheet as a current liability and accumulated other comprehensive loss.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

The Company’s 2009 Annual Report to Stockholders contains management’s discussion and analysis of financial condition and results of operations at and for the year ended April 30, 2009. The following discussion and analysis describes material changes in the Company’s financial condition since April 30, 2009. The analysis of results of operations compares the three and sixnine months ended OctoberJanuary 31, 20092010 with the comparable periodperiods of the prior fiscal year.

Results of Operations

Sales for the three months ended OctoberJanuary 31, 20092010 were $27,088,000,$21,814,000, a decrease of 2%16% from sales of $27,732,000$26,023,000 in the same period last year. Sales from Domestic Operations were $24,713,000, an increase$19,081,000, a decrease of 4%15% from the prior year period. Sales from Domestic Operations for the three month period were affected by a soft market for small laboratory furniture projects, and unusually bad weather which delayed the start of many construction projects. Sales from International Operations were $2,375,000,$2,733,000, a decrease of 40%22% from the prior year period.

Sales for the sixnine months ended OctoberJanuary 31, 20092010 were $53,337,000,$75,151,000, a slight increasedecrease of 5% from sales of $53,127,000$79,150,000 in the same period last year. Sales from Domestic Operations were $48,071,000, an increase of 7% from$67,152,000, relatively unchanged when compared to the prior year period. Sales from International Operations were $5,266,000,$7,999,000, a decrease of 37%33% from the prior year period. The decline in international operationsInternational Operations sales for both the three and sixnine month periods resulted from customer changeslower demand resulting from the slowdown in their product delivery dates.Asia of construction activity. The order backlog at OctoberJanuary 31, 20092010 was $65.2$65.5 million, as compared to a backlog of $62.7 million at April 30, 2009 and $61.6$65.2 million at October 31, 2008.2009 and $60.7 million at January 31, 2009.

The gross profit margin for the three months ended OctoberJanuary 31, 20092010 was 22.9%21.5% of sales, as compared to 21.7%19.0% of sales in the comparable quarter of the prior year. The gross profit margin for the sixnine months ended OctoberJanuary 31, 20092010 was 22.4%22.2% of sales, as compared to 21.4%20.6% of sales in the comparable quarter of the prior year. The increases in the gross profit margin percentages were primarily due to increased manufacturing efficiencies, savings from alternative sources of raw materials and components, and other cost improvements.

Operating expenses for the three months ended OctoberJanuary 31, 20092010 were $3,976,000,$3,663,000, or 14.7%16.8% of sales, as compared to $3,858,000,$3,440,000, or 13.9%13.2% of sales, in the comparable period of the prior year. Operating expenses for the sixnine months ended OctoberJanuary 31, 20092010 were $7,942,000,$11,605,000, or 14.9%15.4% of sales, as compared to $7,444,000,$10,884,000, or 14.0%13.8% of sales, in the comparable period of the prior year. The increase in operating expenses for the current quarter was primarily due to an increase of $286,000$295,000 for costs associated with benefit plans, $208,000 for sales and marketing costs, and an increase of $32,000 in pensiondepreciation expense, partially offset by a decrease inlower expenses of $205,000 related to accrued compensation expense of $127,000.for incentive bonus plans. The increase in operating expenses for the nine months of the current year six-month period was primarily due to an increase of $501,000$234,000 in pensionadministrative salaries, an increase of $753,000 for costs associated with benefit plans, and an increase of $98,000 in depreciation expense, partially offset by a decrease inlower expenses of $392,000 related to accrued compensation expense of $76,000.for incentive bonus plans.

Operating earnings were $2,234,000$1,022,000 and $4,032,000$5,054,000 for the three and sixnine months ended OctoberJanuary 31, 2009.2010. This compares to operating earnings of $2,161,000$1,494,000 and $3,926,000$5,420,000 for the comparable periods of the prior year.

Interest expense was $39,000$35,000 and $80,000$115,000 for the three and sixnine months ended OctoberJanuary 31, 2009,2010, respectively, as compared to $93,000$49,000 and $182,000$231,000 for the comparable periods of the prior year. The decrease in interest expense for the current year periods resulted from lower interest rates paid on advances.advances under the Company’s bank credit facility.

There was no other income and other expense in the three and sixnine months ended OctoberJanuary 31, 2009, respectively,2010, as compared to other income of $1,000$3,000 and $39,000other expense of $36,000 for the comparable periods of the prior year.three and nine months ended January 31, 2009, respectively.

Income tax expense of $751,000$333,000 and $1,340,000$1,673,000 was recorded for the three and sixnine months ended OctoberJanuary 31, 2009,2010, respectively, as compared to income tax expense of $566,000$488,000 and $1,107,000$1,595,000 recorded for the comparable periods of the prior year. The effective tax rates were 34.2%33.7% and 33.9% for the three and sixnine months ended OctoberJanuary 31, 2009,2010, respectively, and were 27.4%33.7% and 29.9%31.0% for the three and six months ended October 31, 2008.comparable periods of the prior year. The effective tax rates for each of the threecurrent year and six monthprior year periods differs fromwere below the statutory rate primarilytax rates due to the impactcombination of varyinglower income tax rates on income earned byin the geographic locations of the Company’s foreign subsidiaries. In addition to this factor,subsidiaries and the impact of state and federal income tax credits on domestic operations income. The higher effective tax rates for all the periods were favorably impacted by earned state and federal tax credits. The increase in the effective tax rates in the current year periodsperiod as compared to the prior year periods resulted primarily fromperiod was due to a lowerhigher portion of taxable earnings in the currentprior year periodsperiod from the Company’s subsidiaries located in geographic locations with lower income tax rates.

Minority interests relaterelated to minority shareholders’ interest in the Company’s two subsidiaries that are not 100% owned by the Company. Minority interestsCompany reduced net earnings by $92,000$33,000 and $189,000$222,000 for the three and sixnine months ended OctoberJanuary 31, 2009,2010, as compared to reductionsa reduction of $37,000$78,000 and $153,000$231,000 for the comparable periods of the prior year. The decrease in minority interests in the current periodyear periods was directly related to lower earnings of the Company’s two subsidiaries.subsidiaries in the current year.

Net earnings were $1,352,000,$621,000, or $0.53$0.24 per diluted share, and $2,423,000,$3,044,000, or $0.95$1.18 per diluted share, for the three and sixnine months ended OctoberJanuary 31, 2009. Net2010. This compares to net earnings were $1,464,000,of $882,000, or $0.57$0.35 per diluted share, and $2,445,000,$3,327,000, or $0.95$1.30 per diluted share, for the three and six-months ended October 31, 2008.comparable periods of the prior year.

Liquidity and Capital Resources

Historically, the Company’s principal sources of liquidity have been funds generated from operations, supplemented as needed by short-term borrowings under the Company’s revolving credit facility. Additionally, certain machinery and equipment are financed by non-cancellable operating leases or capital leases. The Company believes that these sources will be sufficient to support ongoing business requirements, including capital expenditures through the current fiscal year.

The Company had working capital of $20.9$21.3 million at OctoberJanuary 31, 2009,2010, compared to $18.9 million at April 30, 2009. The ratio of current assets to current liabilities was 2.1-to-1.02.6-to-1.0 at OctoberJanuary 31, 2009,2010, compared to 2.0-to-1.0 at April 30, 2009. At OctoberJanuary 31, 2009,2010, advances of $5,370,000$2,909,000 were outstanding under the Company’s bank revolving credit facility, as compared to advances of $5,720,000 outstanding as of April 30, 2009.

The Company’s operations provided cash of $2,073,000$5,027,000 during the sixnine months ended OctoberJanuary 31, 2009.2010. Cash was provided primarily provided from operating earnings which was partially offset by increasedand a decrease of $1,412,000 in accounts receivable of $2,205,000.receivable. The Company’s operations usedprovided cash of $503,000$340,000 during the sixnine months ended OctoberJanuary 31, 2008. Cash2009 as cash provided from operating earnings was primarilysubstantially offset by cash used to fund an increase of $5,537,000$4,800,000 in accounts receivable, which was partially offset by cash provided from operating earnings.receivable.

During the sixnine months ended OctoberJanuary 31, 2009,2010, net cash of $2,283,000$3,130,000 was used byin investing activities, primarily for capital expenditures. This compares to the use of $607,000$1,074,000 for investing activities in the comparable period of the prior year, primarily for capital expenditures.

The Company’s financing activities used cash of $934,000$3,694,000 during the sixnine months ended OctoberJanuary 31, 2009.2010. Cash used included cash dividends of $719,000 paid of $461,000,to stockholders, payments on obligations of capital leases of $144,000, and$186,000, purchases of treasury stock of $114,000$245,000, and $350,000$2,811,000 for a reduction in short-term borrowing,borrowings, partially offset by $135,000$267,000 in proceeds received from the exercise of stock options. FinancingThe Company’s financing activities used cash of $107,000 in$27,000 during the same period for the prior year, whichnine months ended January 31, 2009. Cash used included $408,000 for cash dividends $192,000 forof $498,000 paid to minority interest holders of the Company’s subsidiaries, cash dividends of $613,000 paid to stockholders, payments on obligations of capital leases of $280,000, and $198,000 for the purchasepurchases of treasury stock partially offsetof $198,000. Cash was provided during this period by increasedan increase of $1,264,000 in short-term borrowings of $415,000 and $276,000$298,000 in proceeds received from the exercise of stock options.

Outlook for ThirdFourth Quarter of Fiscal Year 2010

While the Company’s ability to predict future demand for its products continues to be limited given, among other general economic factors affecting the Company and its markets, the Company’s role as subcontractor or supplier to dealers for subcontractors, the Company expects the thirdfourth quarter of fiscal year 2010 to be profitable. In addition to general economic factors affecting the Company and its markets, demand for its products is also dependent upon the number of laboratory construction projects planned and/or current progress in projects already under construction.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain statements in this report constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company’s operations, markets, products, services, and prices, as well as prices for certain raw materials and energy. The cautionary statements made pursuant to the Reform Act herein and elsewhere by the Company should not be construed as exhaustive. The Company cannot always predict what factors would cause actual results to differ materially from those indicated by the forward-looking statements. In addition, readers are urged to consider statements that include the terms “believes”, “belief”, “expects”, “plans”, “objectives”, “anticipates”, “intends” or the like to be uncertain and forward-looking. Over time, the Company’s actual results, performance or achievements will likely differ from the anticipated results, performance or achievements that are expressed or implied by the Company’s forward-looking statements, and such difference might be significant and harmful to stockholders’ interests. Many important factors that could cause such a difference are described under the caption “Risk Factors,” in Item 1A of the Company’s 2009 Annual Report on Form 10-K.

REVIEW BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

A review of the interim consolidated financial information included in this Quarterly Report on Form 10-Q for each of the three and sixnine month periods ended OctoberJanuary 31, 20092010 and OctoberJanuary 31, 20082009 has been performed by Cherry, Bekaert & Holland, L.L.P., the Company’s registered public accounting firm. Their report on the interim consolidated financial information follows.

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have reviewed the accompanying consolidated balance sheetssheet of Kewaunee Scientific Corporation and its subsidiaries (the “Company”) as of OctoberJanuary 31, 2009,2010, and the related consolidated statements of operations for the three month and sixnine month periods ended OctoberJanuary 31, 20092010 and 20082009 and the related consolidated statements of cash flows for the six-monthnine-month periods ended OctoberJanuary 31, 20092010 and 2008.2009. These interim consolidated financial statements are the responsibility of the Company’s management.

We conducted our reviewreviews in accordance with the standards of the Public Company Accounting Oversight Board (United States). A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States), the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our review,reviews, we are not aware of any material modifications that should be made to the interim consolidated financial statements referred to above for them to be in conformity with accounting principles generally accepted in the United States of America.

We previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet as of April 30, 2009 and the related consolidated statements of operations, of stockholders’stockholder’s equity and of cash flows for the year then ended (not presented herein) and in our report dated July 10, 2009, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet as of April 30, 2009 is fairly stated in all material respects in relation to the consolidated financial statement from which it has been derived.

/s/ Cherry, Bekaert & Holland, L.L.P.

Charlotte, North Carolina

December 11, 2009March 12, 2010

Item 3.Quantitative and Qualitative Disclosures About Market Risk

There are no material changes to the disclosures made on this matter in the Company’s Annual Report on Form 10-K for the fiscal year ended April 30, 2009.

 

Item 4.Controls and Procedures

(a) Evaluation of disclosure controls and procedures

An evaluation was performed under the supervision and the participation of the Company’s management, including the Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of OctoberJanuary 31, 2009.2010. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of OctoberJanuary 31, 2009,2010, the Company’s disclosure controls and procedures were adequate and effective and designed to ensure that all material information required to be filed in this quarterly report is made known to them by others within the Company and its subsidiaries.

(b) Changes in internal controls

There was no significant change in the Company’s internal control over financial reporting that occurred during the most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 4.Submission of Matters to a Vote of Security Holders

The Company’s Annual Meeting of Stockholders was held on August 26, 2009. Information regarding the results of this meeting are incorporated by reference from Item 4 of Part II of the Company’s Report on Form 10-Q for the three months ended July 31, 2009.

Item 6.Exhibits

 

31.1  Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2  Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1  Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2  Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

KEWAUNEE SCIENTIFIC CORPORATION

                        (Registrant)

Date: December 11, 2009March 12, 2010  By 

/s/ D. Michael Parker

    

D. Michael Parker

(As duly authorized officer and Senior Vice President, Finance and Chief Financial Officer)

 

1213